| 18th Mar 2013 5:04 pm |
RNS |
Director/PDMR Shareholding |
| 18th Mar 2013 5:02 pm |
RNS |
Director/PDMR Shareholding |
| 18th Mar 2013 5:00 pm |
RNS |
Director/PDMR Shareholding |
| 15th Mar 2013 5:23 pm |
RNS |
Transaction in Own Shares |
| 14th Mar 2013 5:36 pm |
RNS |
Transaction in Own Shares |
| 13th Mar 2013 5:28 pm |
RNS |
Transaction in Own Shares |
| 12th Mar 2013 5:36 pm |
RNS |
Transaction in Own Shares |
| 12th Mar 2013 3:49 pm |
RNS |
Director/PDMR Shareholding |
| 12th Mar 2013 3:34 pm |
RNS |
Director/PDMR Shareholding |
| 11th Mar 2013 5:19 pm |
RNS |
Transaction in Own Shares |
| 11th Mar 2013 10:52 am |
RNS |
GSK files its Annual Report 2012 on Form 20-F |
| 8th Mar 2013 5:23 pm |
RNS |
Transaction in Own Shares |
| 7th Mar 2013 5:43 pm |
RNS |
Transaction in Own Shares |
| 7th Mar 2013 10:32 am |
RNS |
GSK submits albiglutide MAA to the EMA |
| 7th Mar 2013 7:00 am |
RNS |
Dolutegravir SAILING study in HIV announced |
| 6th Mar 2013 5:38 pm |
RNS |
Director/PDMR Shareholding |
| 6th Mar 2013 2:33 pm |
RNS |
Publication of Annual Report 2012 |
| 5th Mar 2013 5:45 pm |
RNS |
Director/PDMR Shareholding |
| 5th Mar 2013 5:43 pm |
RNS |
Director/PDMR Shareholding |
| 5th Mar 2013 5:36 pm |
RNS |
Director/PDMR Shareholding |
| 5th Mar 2013 5:35 pm |
RNS |
Director/PDMR Shareholding |
| 5th Mar 2013 5:33 pm |
RNS |
Director/PDMR Shareholding |
| 5th Mar 2013 2:48 pm |
RNS |
Director/PDMR Shareholding |
| 5th Mar 2013 2:45 pm |
RNS |
Director/PDMR Shareholding |
| 4th Mar 2013 6:27 pm |
RNS |
Director/PDMR Shareholding |
| 4th Mar 2013 6:26 pm |
RNS |
Director/PDMR Shareholding |
| 4th Mar 2013 6:25 pm |
RNS |
Director/PDMR Shareholding |
| 4th Mar 2013 6:23 pm |
RNS |
Director/PDMR Shareholding |
| 4th Mar 2013 4:36 pm |
RNS |
Director/PDMR Shareholding |
| 1st Mar 2013 2:54 pm |
RNS |
Total Voting Rights |
| 25th Feb 2013 9:56 am |
RNS |
Director/PDMR Shareholding |
| 19th Feb 2013 6:04 pm |
RNS |
Director/PDMR Shareholding |
| 18th Feb 2013 4:58 pm |
RNS |
Director/PDMR Shareholding |
| 15th Feb 2013 3:09 pm |
RNS |
Dolutegravir granted FDA priority review |
| 12th Feb 2013 3:15 pm |
RNS |
Director/PDMR Shareholding |
| 12th Feb 2013 3:11 pm |
RNS |
Director/PDMR Shareholding |
| 8th Feb 2013 4:38 pm |
RNS |
Replacement Director/PDMR Shareholding |
| 7th Feb 2013 3:24 pm |
RNS |
EU submission for BRAF/MEK combination therapy |
| 6th Feb 2013 12:16 pm |
RNS |
GSK applies IAS19R with effect from 1 January 2013 |
| 6th Feb 2013 12:01 pm |
RNS |
Final Results |
